Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
GUFICBIO | NSE
14.90
5.44%
Healthcare
Drug Manufacturers-Specialty & Generic
31/03/2024
01/04/2026
288.70
275.15
297.00
275.15
Gufic Biosciences Limited engages in manufacture and marketing of active pharmaceutical ingredients (APIs) generic pharmaceuticals and related services in India. It manufactures APIs and bulk drugs such as antifungals anesthetics immuno suppressants and intermediates for antifungals. The company also manufactures lyophilized injections which include antibiotic antifungal cardiac infertility antiviral and proton-pump inhibitor segments. In addition it offers spark criti care and ferticare pharmaceutical products; and herbal and personal care products. The company supplies its products to hospital chains and medical facilities. It also exports its products to more than 20 countries. The company was founded in 1970 and is based in Mumbai India.
View LessHigh Short-term Volatility
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
62.7%1 month
47.6%3 months
36.8%6 months
32.6%50.00
-
7.99
0.63
0.30
31.17
5.96
-
1.47B
28.96B
310.78M
0.02
15.52
-2.30
4.00
19.57
-
-
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
30.25
Range1M
35.25
Range3M
76.70
Rel. volume
0.77
Price X volume
13.56M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Aarti Drugs Limited | AARTIDRUGS | Drug Manufacturers-Specialty & Generic | 346.4 | 31.66B | 8.33% | 27.18 | 44.03% |
| RPG Life Sciences Limited | RPGLIFE | Drug Manufacturers-Specialty & Generic | 1877.6 | 31.07B | 1.07% | 50.00 | 0.00% |
| ZOTA | ZOTA | Biotechnology | 1116.2 | 28.94B | 4.83% | n/a | 105.90% |
| Orchid Pharma Limited | ORCHPHARMA | Drug Manufacturers-Specialty & Generic | 519.3 | 26.44B | 7.64% | 59.92 | 11.56% |
| Bliss Gvs Pharma Limited | BLISSGVS | Drug Manufacturers-Specialty & Generic | 229.4 | 24.16B | 6.41% | 17.04 | 10.32% |
| Dishman Carbogen Amcis Limited | DCAL | Biotechnology | 146.14 | 22.91B | 12.44% | n/a | 41.09% |
| Unichem Laboratories Limited | UNICHEMLAB | Drug Manufacturers-Specialty & Generic | 298.2 | 21.07B | 1.62% | n/a | 10.48% |
| Morepen Laboratories Limited | MOREPENLAB | Drug Manufacturers-Specialty & Generic | 37.2 | 20.55B | 10.45% | 37.53 | 3.42% |
| Panacea Biotec Limited | PANACEABIO | Biotechnology | 325.3 | 20.30B | 9.88% | n/a | 2.49% |
| SOLARA | SOLARA | Drug Manufacturers-Specialty & Generic | 459.1 | 19.89B | 7.88% | n/a | 107.90% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Vertoz Advertising Limited | VERTOZ | Advertising Agencies | 31.14 | 27.32B | 10.46% | 48.67 | 10.74% |
| "SAI SILKS (KALAMANDIR) LIMITED " | KALAMANDIR | Apparel Retail | 101.34 | 14.93B | 12.25% | 28.83 | 43.67% |
| Signpost India Limited | SIGNPOST | Advertising Agencies | 231.11 | 13.55B | 4.36% | 30.54 | 80.30% |
| V2 Retail Limited | V2RETAIL | Apparel Retail | 189.42 | 6.76B | 0.17% | 120.49 | 191.28% |
| Bhagyanagar India Ltd | BHAGYANGR | Copper | 151.06 | 4.88B | 9.69% | 36.36 | 52.08% |
| Madhav Copper Limited | MCL | Copper | 57.49 | 1.59B | 4.99% | 82.22 | 32.14% |
| Cubex Tubings Limited | CUBEXTUB | Copper | 83.8 | 1.22B | 13.34% | 35.85 | 21.78% |
| Touchwood Entertainment Limited | TOUCHWOOD | Advertising Agencies | 65.89 | 734.59M | 4.50% | 50.06 | 4.88% |
| Sagardeep Alloys Limited | SAGARDEEP | Copper | 22.89 | 397.37M | 3.95% | 58.62 | 43.14% |
| Heads UP Ventures Limited | HEADSUP | Apparel Retail | 6.92 | 151.62M | 14.38% | n/a | 0.00% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 31.17 | 24.85 | Expensive |
| Ent. to Revenue | 5.96 | 11.40 | Cheaper |
| PE Ratio | 50.00 | 51.36 | Par |
| Price to Book | 7.99 | 6.83 | Par |
| Dividend Yield | 0.02 | 0.52 | Poor |
| Std. Deviation (3M) | 36.77 | 42.17 | Par |
| Debt to Equity | 0.63 | 0.35 | Expensive |
| Debt to Assets | 0.30 | 0.17 | Expensive |
| Market Cap | 28.96B | 290.82B | Emerging |